Table of Content

Open Access iconOpen Access

ARTICLE

Mitral valve prolapse and Marfan syndrome

Amitabh Thacoor

Department of Cardiac Surgery, Leeds General Infirmary, Great George Street, Leeds, United KIngdom

* Corresponding Author: Amitabh Thacoor, Department of Plastic and Reconstructive Surgery, Royal Free Hospital, Pond Street, London, NW32QG, UK. Email: email

Congenital Heart Disease 2017, 12(4), 430-434. https://doi.org/10.1111/chd.12467

Abstract

Marfan syndrome is a multisystemic genetic condition affecting connective tissue. It carries a reduced life expectancy, largely dependent on cardiovascular complications. More common cardiac manifestations such as aortic dissection and aortic valve incompetence have been widely documented in the literature. Mitral valve prolapse (MVP), however, has remained poorly documented. This article aims at exploring the existing literature on the pathophysiology and diagnosis of MVP in patients with Marfan syndrome, defining its current management and outlining the future developments surrounding it.

Keywords


Cite This Article

APA Style
Thacoor, A. (2017). Mitral valve prolapse and marfan syndrome. Congenital Heart Disease, 12(4), 430-434. https://doi.org/10.1111/chd.12467
Vancouver Style
Thacoor A. Mitral valve prolapse and marfan syndrome. Congeni Heart Dis. 2017;12(4):430-434 https://doi.org/10.1111/chd.12467
IEEE Style
A. Thacoor, “Mitral valve prolapse and Marfan syndrome,” Congeni. Heart Dis., vol. 12, no. 4, pp. 430-434, 2017. https://doi.org/10.1111/chd.12467



cc Copyright © 2017 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1404

    View

  • 1077

    Download

  • 0

    Like

Related articles

Share Link